<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Aksu T</submitter><funding>NHLBI NIH HHS</funding><pagination>183-191</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12064083</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>68(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Cardioneuroablation has been emerging as a potential treatment alternative in appropriately selected patients with cardioinhibitory vasovagal syncope (VVS) and functional AV block (AVB). However the majority of available evidence has been derived from retrospective cohort studies performed by experienced operators.&lt;h4>Methods&lt;/h4>The Cardioneuroablation for the Management of Patients with Recurrent Vasovagal Syncope and Symptomatic Bradyarrhythmias (CNA-FWRD) Registry is a multicenter prospective registry with cross-over design evaluating acute and long-term outcomes of VVS and AVB patients treated by conservative therapy and CNA.&lt;h4>Results&lt;/h4>The study is a prospective observational registry with cross-over design for analysis of outcomes between a control group (i.e.</pubmed_abstract><journal>Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing</journal><pubmed_title>Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry.</pubmed_title><pmcid>PMC12064083</pmcid><funding_grant_id>K23 HL145017</funding_grant_id><pubmed_authors>Kumar V</pubmed_authors><pubmed_authors>Gerstenfeld E</pubmed_authors><pubmed_authors>Salcedo J</pubmed_authors><pubmed_authors>Piccini J</pubmed_authors><pubmed_authors>Woods CE</pubmed_authors><pubmed_authors>Gopinathannair R</pubmed_authors><pubmed_authors>Sundaram S</pubmed_authors><pubmed_authors>Dewland T</pubmed_authors><pubmed_authors>Sood N</pubmed_authors><pubmed_authors>Bradfield JS</pubmed_authors><pubmed_authors>Kapur S</pubmed_authors><pubmed_authors>DeSimone C</pubmed_authors><pubmed_authors>Joza JE</pubmed_authors><pubmed_authors>Perino A</pubmed_authors><pubmed_authors>Shivkumar K</pubmed_authors><pubmed_authors>Alyesh D</pubmed_authors><pubmed_authors>Rodgers AJ</pubmed_authors><pubmed_authors>Gautam S</pubmed_authors><pubmed_authors>Sauer W</pubmed_authors><pubmed_authors>Forno ARJD</pubmed_authors><pubmed_authors>Enriquez A</pubmed_authors><pubmed_authors>De Potter T</pubmed_authors><pubmed_authors>Markman TM</pubmed_authors><pubmed_authors>Aksu T</pubmed_authors><pubmed_authors>Do DH</pubmed_authors><pubmed_authors>Rav-Acha M</pubmed_authors><pubmed_authors>Hussein A</pubmed_authors><pubmed_authors>Singh D</pubmed_authors><pubmed_authors>Upadhyay G</pubmed_authors><pubmed_authors>du Fay de Lavallaz J</pubmed_authors><pubmed_authors>Valeriano C</pubmed_authors><pubmed_authors>Sharma PS</pubmed_authors><pubmed_authors>d'Avila A</pubmed_authors><pubmed_authors>Winterfield JR</pubmed_authors><pubmed_authors>Baykaner T</pubmed_authors><pubmed_authors>Tung R</pubmed_authors><pubmed_authors>Alfie A</pubmed_authors><pubmed_authors>Kumar K</pubmed_authors><pubmed_authors>Atwater BD</pubmed_authors><pubmed_authors>Santangeli P</pubmed_authors><pubmed_authors>Osorio J</pubmed_authors><pubmed_authors>Tzou WS</pubmed_authors><pubmed_authors>Badertscher P</pubmed_authors><pubmed_authors>Huang HD</pubmed_authors><pubmed_authors>Glikson M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry.</name><description>&lt;h4>Background&lt;/h4>Cardioneuroablation has been emerging as a potential treatment alternative in appropriately selected patients with cardioinhibitory vasovagal syncope (VVS) and functional AV block (AVB). However the majority of available evidence has been derived from retrospective cohort studies performed by experienced operators.&lt;h4>Methods&lt;/h4>The Cardioneuroablation for the Management of Patients with Recurrent Vasovagal Syncope and Symptomatic Bradyarrhythmias (CNA-FWRD) Registry is a multicenter prospective registry with cross-over design evaluating acute and long-term outcomes of VVS and AVB patients treated by conservative therapy and CNA.&lt;h4>Results&lt;/h4>The study is a prospective observational registry with cross-over design for analysis of outcomes between a control group (i.e.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-05-29T05:03:00.885Z</modification><creation>2026-04-08T03:44:42.115Z</creation></dates><accession>S-EPMC12064083</accession><cross_references><pubmed>38499825</pubmed><doi>10.1007/s10840-024-01789-9</doi></cross_references></HashMap>